|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/513 | (2006.01) |
| A61K 9/2018 | (2013.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61K 31/513 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/2027 | (2013.01) | ||
| A61K 9/2059 | (2013.01) | ||
| A61K 9/2013 | (2013.01) | ||
| A61K 9/2813 | (2013.01) | ||
| A61K 9/284 | (2013.01) | ||
| A61K 9/2853 | (2013.01) | ||
| A61K 9/2009 | (2013.01) | ||
| A61K 9/2866 | (2013.01) | ||
| A61K 9/2826 | (2013.01) |
| (11) | Number of the document | 4279075 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22461549.2 |
| Date of filing the European patent application | 2022-05-12 | |
| (97) | Date of publication of the European application | 2023-11-22 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-10 |
| (46) | Date of publication of the claims translation |
| (72) |
Skoczen, Przemyslaw , PL
Hrakovsky, Julia , PL
|
| (73) |
Zaklady Farmaceutyczne Polpharma S.A. ,
ul. Pelplinska 19, 83-200 Starogard Gdanski,
PL
|
| (54) | A PHARMACEUTICAL COMPOSITION COMPRISING ELAGOLIX |
| A PHARMACEUTICAL COMPOSITION COMPRISING ELAGOLIX |